What are the common dosing regimens for cefazolin (Ancef) in adults and children, including adjustments for normal renal function, moderate renal impairment, and severe renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Common Cefazolin (Ancef) Dosing

For adults with normal renal function, cefazolin is dosed at 1-2 grams every 8 hours for moderate to severe infections, with doses ranging from 500 mg to 1 gram every 6-8 hours depending on infection severity. 1

Adult Dosing by Indication

Treatment Dosing (Normal Renal Function)

  • Moderate to severe infections: 500 mg to 1 gram IV every 6-8 hours 1
  • Mild infections (susceptible gram-positive cocci): 250-500 mg IV every 8 hours 1
  • Severe/life-threatening infections (endocarditis, septicemia): 1-1.5 grams IV every 6 hours 1
  • Uncomplicated UTI: 1 gram IV every 12 hours 1
  • Pneumococcal pneumonia: 500 mg IV every 12 hours 1
  • MSSA infections (skin/soft tissue): 1 gram IV every 8 hours 2, 3
  • MSSA pneumonia: 150 mg/kg/day divided every 8 hours 4

In rare cases of extremely severe infections, doses up to 12 grams daily have been used 1.

Surgical Prophylaxis

  • Preoperative: 2 grams IV given 30-60 minutes before incision (3 grams if ≥120 kg) 1
  • Intraoperative redosing: 1 gram IV every 2-4 hours for prolonged procedures 1
  • Postoperative: 500 mg to 1 gram IV every 6-8 hours for 24 hours 1
  • High-risk surgery (cardiac, prosthetic joints): May continue 3-5 days postoperatively 1

The timing is critical—the preoperative dose must be given 30-60 minutes before incision to ensure adequate tissue levels at the time of surgical exposure 1.

Pediatric Dosing

Treatment (Normal Renal Function)

  • Mild to moderate infections: 25-50 mg/kg/day divided every 6-8 hours 1
  • Severe infections: Up to 100 mg/kg/day (maximum 45 mg/lb/day) 1
  • MSSA pneumonia: 150 mg/kg/day divided every 8 hours 4

Important caveat: Cefazolin is not recommended for premature infants and neonates due to lack of safety data 1.

Renal Impairment Dosing

Adults

After an initial full loading dose appropriate to infection severity 1:

  • CrCl ≥55 mL/min (SCr ≤1.5 mg/dL): Full dose, no adjustment needed 1
  • CrCl 35-54 mL/min (SCr 1.6-3.0 mg/dL): Full dose but extend interval to at least every 8 hours 1
  • CrCl 11-34 mL/min (SCr 3.1-4.5 mg/dL): 50% of usual dose every 12 hours 1
  • CrCl ≤10 mL/min (SCr ≥4.6 mg/dL): 50% of usual dose every 18-24 hours 1

The serum half-life extends from 1.6-2.2 hours in normal function to approximately 42 hours in anephric patients 5, 6.

Pediatric Renal Impairment

After an initial loading dose 1:

  • CrCl 40-70 mL/min: 60% of normal daily dose divided every 12 hours 1
  • CrCl 20-40 mL/min: 25% of normal daily dose divided every 12 hours 1
  • CrCl 5-20 mL/min: 10% of normal daily dose every 24 hours 1

Key Clinical Pearls

Obesity considerations: Standard weight-based dosing may be inadequate in patients with obesity, particularly for achieving therapeutic concentrations in subcutaneous adipose tissue 7. For surgical prophylaxis in patients ≥120 kg, use 3 grams preoperatively 1, 8.

CNS infections: For MSSA meningitis, high-dose continuous infusion (6-12 g/day) or intermittent dosing of 2 grams every 6 hours may be required to achieve adequate CSF concentrations, as the CSF:plasma ratio is only approximately 0.0525 9, 10.

Dialysis: Cefazolin is removed by hemodialysis; supplemental dosing post-dialysis is necessary 6, 11. The elimination rate constant correlates linearly with creatinine clearance (Ke = 0.022 + 0.0028 × CrCl) 12.

Always give a loading dose in renal impairment—the loading dose is not affected by renal function, only maintenance dosing 1.

References

Research

Use of antibacterial agents in renal failure.

Infectious disease clinics of North America, 2000

Related Questions

What are the dosing guidelines, contraindications, and safety considerations for cefazolin, including adjustments for renal impairment, pediatric patients, and surgical prophylaxis?
What is the recommended intravenous dose and infusion rate for cefazolin, including adjustments for infection severity and renal impairment?
What is the appropriate cefazolin (Ancef) dose for a 13‑year‑old patient?
What is the recommended cefazolin (Ancef) dosing for adults for surgical prophylaxis and infection treatment, including adjustments for renal impairment?
What is the recommended cefazolin dosing regimen for gram‑negative bacteremia in an adult with normal renal function, and how should the dose be adjusted in cases of moderate to severe renal impairment?
How should sertraline be tapered in a patient taking 100 mg daily who is also on duloxetine 20 mg twice daily for chronic neuropathic pain—should it be discontinued abruptly or reduced gradually?
What is the diagnosis and recommended management for a patient with ferritin 6 µg/L, hemoglobin 10 g/dL, hematocrit 33 %, MCV 71 fL, MCH 21 pg, MCHC 29 g/dL, RDW 18 % and platelet count 436 ×10⁹/L?
Is delivering in the seventh month (28–31 weeks gestation) versus the eighth month (32–35 weeks gestation) more risky for the newborn’s breathing, and is this risk factual or a myth?
What is the recommended evaluation and management when immunohistochemistry shows loss of MLH1, MSH2, and MSH6 expression?
What are the cardiovascular benefits of estrogen replacement therapy in a post‑menopausal woman (age 55‑65) without a history of coronary disease?
In a 2-year-old child with vesicular and pustular lesions on the feet, hands, and buttocks who is very irritable and cannot tolerate oral intake, what diagnosis should be suspected?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.